Theodore H. Stanley, Director at Insys Therapeutics, Inc. (INSY), sold 16,000 shares at $16.27 ($260K) on 2016-06-06, disclosed to the SEC on 2016-06-06.
Open-market sale of $260k INSY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INSY | SELL | 2015-09-14 | $148K | — | Filing → |
| INSY | SELL | 2015-03-10 | $198K | — | Filing → |
| INSY | SELL | 2015-03-06 | $403K | — | Filing → |